Yes. Very happy with this report.
The revenue reported (note: 1a) was only for the month of September (since re-listing). Its a SaaS business - Opex, repeat, recurring revenue which I like. PaaS sales in Colombia (note: 9.7) were significant clients. They used capital but I guess with the new Chairman's banking background, they will seek alternate financing arrangement in future (and maybe even re-finance the existing).
New distributors in 2 new countries. Product application expansion from radiology to cardiology (pilot progressing to commercial) and pathology (pilot). Both points demonstrate execution of a plan.
Steady as she goes.
Ann: Quarterly Cash Flow and Summary of Activities, page-6
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 17167 | 1 |
View Market Depth
| Last trade - 16.12pm 03/12/2024 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable
